Investigational Site Number : 2500001

Dijon 21079

1 studies enrolling now · 2 studies all time

What they study most

Immune Thrombocytopenia, Neoplasm

Studies at this site

• Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment — Recruiting now
• Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors — Stopped early